SI1618873T1 - Granulat za kontrolirano sproščanje tamsulozina, ki vsebuje alginat - Google Patents

Granulat za kontrolirano sproščanje tamsulozina, ki vsebuje alginat

Info

Publication number
SI1618873T1
SI1618873T1 SI200430404T SI200430404T SI1618873T1 SI 1618873 T1 SI1618873 T1 SI 1618873T1 SI 200430404 T SI200430404 T SI 200430404T SI 200430404 T SI200430404 T SI 200430404T SI 1618873 T1 SI1618873 T1 SI 1618873T1
Authority
SI
Slovenia
Prior art keywords
tamsulosin
controlled release
polyvinyl acetate
acetate phthalate
copolymer
Prior art date
Application number
SI200430404T
Other languages
English (en)
Inventor
Eszter Julianna Dr Biro
Waltraud Dr Bueb
Original Assignee
Siegfried Generics Int Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Siegfried Generics Int Ag filed Critical Siegfried Generics Int Ag
Publication of SI1618873T1 publication Critical patent/SI1618873T1/sl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
SI200430404T 2004-07-14 2004-07-14 Granulat za kontrolirano sproščanje tamsulozina, ki vsebuje alginat SI1618873T1 (sl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP04016523A EP1618873B1 (de) 2004-07-14 2004-07-14 Granulat zur kontrollierten Freisetzung von Tamsulosin, enthaltend Alginat

Publications (1)

Publication Number Publication Date
SI1618873T1 true SI1618873T1 (sl) 2007-10-31

Family

ID=34925746

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200430404T SI1618873T1 (sl) 2004-07-14 2004-07-14 Granulat za kontrolirano sproščanje tamsulozina, ki vsebuje alginat

Country Status (15)

Country Link
US (1) US20090130200A1 (sl)
EP (1) EP1618873B1 (sl)
AT (1) ATE363894T1 (sl)
AU (1) AU2005261958A1 (sl)
CA (1) CA2570153A1 (sl)
DE (1) DE502004004032D1 (sl)
DK (1) DK1618873T3 (sl)
ES (1) ES2287613T3 (sl)
NO (1) NO20070559L (sl)
PL (1) PL1618873T3 (sl)
PT (1) PT1618873E (sl)
SI (1) SI1618873T1 (sl)
TW (1) TW200613007A (sl)
WO (1) WO2006005512A1 (sl)
ZA (1) ZA200700216B (sl)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20052461A1 (it) * 2005-12-22 2007-06-23 Univ Degli Studi Milano Sistemi microparticellari per la somministrazione orale di sostanze biologicamente attive
US20080113030A1 (en) * 2006-11-09 2008-05-15 Ching-Fen Hsiao Sustained release tamsulosin formulations
DE102007009242A1 (de) 2007-02-22 2008-09-18 Evonik Röhm Gmbh Pellets mit magensaftresistenter Wirkstoff-Matix
ES2555485T1 (es) 2014-05-26 2016-01-04 Galenicum Health S.L. Composiciones farmacéuticas que contienen un agente activo
AU2017233134A1 (en) * 2016-03-16 2018-10-04 Hanmi Pharm. Co., Ltd. Dutasteride- and tamsulosin-containing hard capsule complex and preparation method therefor
MX2018013473A (es) * 2016-05-04 2019-02-28 Aspen Park Pharmaceuticals Inc Clorhidrato de tamsulosina oral de liberacion retardada.
EP3473245A1 (en) 2017-10-20 2019-04-24 Veru Inc. Controlled release oral tamsulosin hydrochloride
EP3473244A1 (en) 2017-10-20 2019-04-24 Veru Inc. Controlled release oral tamsulosin hydrochloride
CN115300506A (zh) * 2022-08-11 2022-11-08 南京红地生物科技有限公司 含有坦索罗辛和米拉贝隆的复方制剂及其制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4772475A (en) * 1985-03-08 1988-09-20 Yamanouchi Pharmaceutical Co., Ltd. Controlled-release multiple units pharmaceutical formulation
US5695781A (en) * 1995-03-01 1997-12-09 Hallmark Pharmaceuticals, Inc. Sustained release formulation containing three different types of polymers
US6251430B1 (en) * 1998-02-04 2001-06-26 Guohua Zhang Water insoluble polymer based sustained release formulation
EP1413294B1 (en) * 2001-07-27 2010-09-29 Astellas Pharma Inc. Composition comprising sustained-release fine particles for quick-disintegrating tablets in the buccal cavity
US7018658B2 (en) * 2002-11-14 2006-03-28 Synthon Bv Pharmaceutical pellets comprising tamsulosin
KR100510270B1 (ko) * 2002-11-29 2005-08-26 센츄론(주) 펠렛타이저를 이용한 서방성 제제의 제조방법
IN192381B (sl) * 2002-12-20 2004-04-10 Ranbaxy Lab

Also Published As

Publication number Publication date
ES2287613T3 (es) 2007-12-16
NO20070559L (no) 2007-01-30
AU2005261958A1 (en) 2006-01-19
EP1618873A1 (de) 2006-01-25
CA2570153A1 (en) 2006-01-19
DK1618873T3 (da) 2007-10-08
EP1618873B1 (de) 2007-06-06
TW200613007A (en) 2006-05-01
PT1618873E (pt) 2007-09-04
PL1618873T3 (pl) 2008-01-31
ZA200700216B (en) 2008-05-28
ATE363894T1 (de) 2007-06-15
DE502004004032D1 (de) 2007-07-19
US20090130200A1 (en) 2009-05-21
WO2006005512A1 (en) 2006-01-19

Similar Documents

Publication Publication Date Title
NO20070559L (no) Granuler for kontrollert frigjoring av tamsulosin
CA1332567C (en) Sustained release pharmaceutical composition
RU2008130891A (ru) Твердый препарат с контролируемым высвобождением
US5472708A (en) Pulsatile particles drug delivery system
RU2001104535A (ru) Таблетка с энтеросолюбильным покрытием и способ приготовления
BRPI0512452A (pt) processo de encapsulamento e microcápsula
AU2005226927B2 (en) Gastroresistant pharmaceutical dosage form comprising N-(2-(2-phthalimidoethoxy)-acetyl)-L-alanyl-D-glutamic acid (LK-423)
AR069500A1 (es) Metodos de tratamiento de la esteatohepatitis no alcoholica (nash ) utilizando productos de cisteamina
WO2012091153A3 (en) Orally disintegrating tablet
JP2007530492A5 (sl)
CA2581002A1 (en) Less abusable pharmaceutical preparations
WO2008002657A3 (en) Microparticles containing active agent dispersed in a polymer matrix as implant or as coating for medical devices
WO2008101743A3 (de) Pellets mit magensaftresistenter wirkstoff-matrix
TW200602085A (en) Controlled-release pharmaceutical composition and method for producing same
TW200635618A (en) Solid dosage form comprising proton pump inhibitor and suspension made thereof
JP2009538901A (ja) 複式ユニット製薬的製剤
ATE396712T1 (de) Pharmazeutische zubereitung zur modifizierten freisetzung
AP2002002410A0 (en) Hydrodynamically Balancing Oral Drug Delivery System
Sande Pectin-based oral drug delivery to the colon
WO2008048469A3 (en) Controlled-release coated dosage forms containing galantamine
RU2005121999A (ru) Фармацевтические композиции тамсулозина с контролируемым высвобождением
FI3324948T3 (fi) Monikerroksisia farmaseuttisesti aktiivista yhdistettä vapauttavia mikropartikkeleita nestemäisessä annosmuodossa
BG107157A (en) Sustained release beadlets containing stavudine
WO2006122925A3 (fr) Medicament oral a base d'inhibiteur de pompe a protons
AR071970A1 (es) Composicion de liberacion pulsatil de sildenafil y proceso para prepararla